|Other Names||C-terminal-binding protein 2, CtBP2, CTBP2|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP2897b was selected from the C-term region of human CTBP2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Corepressor targeting diverse transcription regulators. Functions in brown adipose tissue (BAT) differentiation (By similarity).|
|Cellular Location||Nucleus. Cell junction, synapse|
|Tissue Location||Ubiquitous. Highest levels in heart, skeletal muscle, and pancreas|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
CTBP2 is Involved in controlling the equilibrium between tubular and stacked structures in the Golgi complex. This protein has dehydrogenase activity.
Bergman,L.M.,et.al., Mol. Cell. Biol. 29 (16), 4539-4551 (2009)
If you have any additional inquiries please email technical services at email@example.com.